Seminars in Radiation Oncology
Volume 22, Issue 1 , Pages 3-10 , January 2012

Quality, Technology and Outcomes: Evolution and Evaluation of New Treatments and/or New Technology

  • Benedick A. Fraass, PhD

      Affiliations

    • Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA
    • Corresponding Author InformationAddress reprint requests to Benedick A. Fraass, PhD, CSMC/Radiation Oncolog, 8700 Beverly Boulevard, AC 1023, Los Angeles, CA 90048
  • ,
  • Jean M. Moran, PhD

      Affiliations

    • Department of Radiation Oncology, University of Michigan, Ann Arbor, MI

  • Image Result

    Anatomic descriptions of the prostate with and without CT. (A) Before CT and (B) contours on an axial CT scan.

    Anatomic descriptions of the prostate with and without CT. (A) Before CT and (B) contours on an axial CT scan.

  • Image Result

    (A) Four-field box plan for the prostate, 2-D planning. (B) Nonaxial 4-field prostate plan, 3-D planning. (C) Seven-field IMRT treatment of head/neck cancer, with beam intensities shown for the indivi

    (A) Four-field box plan for the prostate, 2-D planning. (B) Nonaxial 4-field prostate plan, 3-D planning. (C) Seven-field IMRT treatment of head/neck cancer, with beam intensities shown for the individual beam directions.

  • Image Result
    Isocomplication curve 1 is used for initial treatments. If technology improves conformality of high dose (ie, less normal tissue volume) for a given patient, the prescription dose moves in the directi

    Isocomplication curve 1 is used for initial treatments. If technology improves conformality of high dose (ie, less normal tissue volume) for a given patient, the prescription dose moves in the direction of arrow A toward higher dose. If toxicity on curve 1 is low enough, then escalate to curve 2 (as shown by arrow B), which allows a higher treatment dose for the same volume irradiated. Technology improvement again allows motion on the isocomplication curve toward higher tumor doses.

PII: S1053-4296(11)00100-7

doi: 10.1016/j.semradonc.2011.09.009

Seminars in Radiation Oncology
Volume 22, Issue 1 , Pages 3-10 , January 2012